Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MATTHEW LINDQUIST

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Psychiatric/Mental Health

NPI
1710969159
CMS profile
11236376
Location
ST LOUIS, MO

General Payments · PY2021–2024

$41,651.32

  • Reported across 682 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,239.21

67 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $8,631.27 272
PY2022 $12,399.61 204
PY2023 $9,381.23 139
PY2024 $11,239.21 67

Payment records · PY2024 (67)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Alkermes, Inc. $6.52 01/16/2024 Food and Beverage Undisputed 01/23/2026 1120542489 CMS
Alkermes, Inc. $6.66 01/16/2024 Food and Beverage Undisputed 01/23/2026 1120542491 CMS
Alkermes, Inc. $18.90 02/01/2024 Food and Beverage Undisputed 01/23/2026 1120542493 CMS
Alkermes, Inc. $19.27 02/13/2024 Food and Beverage Undisputed 01/23/2026 1120542495 CMS
Alkermes, Inc. $12.28 03/19/2024 Food and Beverage Undisputed 01/23/2026 1120542497 CMS
Alkermes, Inc. $57.17 06/26/2024 Food and Beverage Undisputed 01/23/2026 1120542499 CMS
Alkermes, Inc. $50.70 12/11/2024 Food and Beverage Undisputed 01/23/2026 1120542501 CMS
AstraZeneca Pharmaceuticals LP $85.61 12/04/2024 Food and Beverage Undisputed 01/23/2026 1105543097 CMS
Axsome Therapeutics, Inc. $24.22 01/25/2024 Food and Beverage Undisputed 01/23/2026 1148390698 CMS
Axsome Therapeutics, Inc. $122.35 04/18/2024 Food and Beverage Undisputed 01/23/2026 1148390700 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.41 01/09/2024 Food and Beverage Undisputed 01/23/2026 1143534491 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.40 01/09/2024 Food and Beverage Undisputed 01/23/2026 1143534493 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $4.42 01/17/2024 Food and Beverage Undisputed 01/23/2026 1143534495 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.37 01/25/2024 Food and Beverage Undisputed 01/23/2026 1143534497 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.41 02/09/2024 Food and Beverage Undisputed 01/23/2026 1143534499 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.13 02/28/2024 Food and Beverage Undisputed 01/23/2026 1143534501 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.16 03/20/2024 Food and Beverage Undisputed 01/23/2026 1143534503 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $0.72 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143534506 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $5.16 04/03/2024 Food and Beverage Undisputed 01/23/2026 1143534508 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $21.43 04/05/2024 Food and Beverage Undisputed 01/23/2026 1143534510 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.12 04/10/2024 Food and Beverage Undisputed 01/23/2026 1143534512 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $2.16 04/10/2024 Food and Beverage Undisputed 01/23/2026 1143534514 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $25.05 04/25/2024 Food and Beverage Undisputed 01/23/2026 1143534516 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $12.99 06/13/2024 Food and Beverage Undisputed 01/23/2026 1143534518 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $40.67 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143534520 CMS
Neurocrine Biosciences, Inc. $23.75 03/08/2024 Food and Beverage Undisputed 01/23/2026 1150960442 CMS
Neurocrine Biosciences, Inc. $16.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 1150995984 CMS
Otsuka America Pharmaceutical, Inc. $10.90 01/26/2024 Food and Beverage Undisputed 01/23/2026 1119123146 CMS
Otsuka America Pharmaceutical, Inc. $1,160.00 02/28/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1119123148 CMS
Otsuka America Pharmaceutical, Inc. $20.81 03/07/2024 Food and Beverage Undisputed 01/23/2026 1119123150 CMS
Otsuka America Pharmaceutical, Inc. $20.75 03/21/2024 Food and Beverage Undisputed 01/23/2026 1119123152 CMS
Otsuka America Pharmaceutical, Inc. $924.37 03/22/2024 Travel and Lodging Undisputed 01/23/2026 1119123154 CMS
Otsuka America Pharmaceutical, Inc. $1,695.00 03/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1119123156 CMS
Otsuka America Pharmaceutical, Inc. $20.50 04/04/2024 Food and Beverage Undisputed 01/23/2026 1119123158 CMS
Otsuka America Pharmaceutical, Inc. $161.00 06/07/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1119123160 CMS
Otsuka America Pharmaceutical, Inc. $125.00 06/28/2024 Food and Beverage Undisputed 01/23/2026 1119123162 CMS
Otsuka America Pharmaceutical, Inc. $116.56 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1119123164 CMS
Otsuka America Pharmaceutical, Inc. $901.75 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1119123166 CMS
Otsuka America Pharmaceutical, Inc. $303.97 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1119123168 CMS
Otsuka America Pharmaceutical, Inc. $214.80 06/28/2024 Travel and Lodging Undisputed 01/23/2026 1119123170 CMS
Otsuka America Pharmaceutical, Inc. $25.00 06/29/2024 Food and Beverage Undisputed 01/23/2026 1119123172 CMS
Otsuka America Pharmaceutical, Inc. $50.00 06/29/2024 Food and Beverage Undisputed 01/23/2026 1119123174 CMS
Otsuka America Pharmaceutical, Inc. $50.00 06/29/2024 Food and Beverage Undisputed 01/23/2026 1119123176 CMS
Otsuka America Pharmaceutical, Inc. $95.12 07/30/2024 Food and Beverage Undisputed 01/23/2026 1119123178 CMS
Otsuka America Pharmaceutical, Inc. $1,606.34 08/09/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1119123180 CMS
Otsuka Pharmaceutical Development & Commercialization, Inc. $29.84 03/01/2024 Food and Beverage Undisputed 01/23/2026 1118842571 CMS
Teva Pharmaceuticals USA, Inc. $15.17 01/18/2024 Food and Beverage Undisputed 01/23/2026 1151498215 CMS
Teva Pharmaceuticals USA, Inc. $125.44 01/24/2024 Food and Beverage Undisputed 01/23/2026 1151498235 CMS
Teva Pharmaceuticals USA, Inc. $16.24 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151498319 CMS
Teva Pharmaceuticals USA, Inc. $1,200.00 01/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1151498321 CMS
Teva Pharmaceuticals USA, Inc. $167.77 01/26/2024 Food and Beverage Undisputed 01/23/2026 1151498343 CMS
Teva Pharmaceuticals USA, Inc. $351.81 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1151498357 CMS
Teva Pharmaceuticals USA, Inc. $212.53 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1151498359 CMS
Teva Pharmaceuticals USA, Inc. $153.83 01/26/2024 Travel and Lodging Undisputed 01/23/2026 1151498361 CMS
Teva Pharmaceuticals USA, Inc. $27.28 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151498345 CMS
Teva Pharmaceuticals USA, Inc. $38.19 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151498347 CMS
Teva Pharmaceuticals USA, Inc. $40.92 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151498349 CMS
Teva Pharmaceuticals USA, Inc. $60.00 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151498351 CMS
Teva Pharmaceuticals USA, Inc. $75.00 01/27/2024 Food and Beverage Undisputed 01/23/2026 1151498353 CMS
Teva Pharmaceuticals USA, Inc. $94.55 01/27/2024 Travel and Lodging Undisputed 01/23/2026 1151498363 CMS
Teva Pharmaceuticals USA, Inc. $18.43 02/01/2024 Food and Beverage Undisputed 01/23/2026 1151498237 CMS
Teva Pharmaceuticals USA, Inc. $14.82 02/22/2024 Food and Beverage Undisputed 01/23/2026 1151498239 CMS
Teva Pharmaceuticals USA, Inc. $10.87 03/27/2024 Food and Beverage Undisputed 01/23/2026 1151498275 CMS
Validus Pharmaceuticals LLC $72.75 05/22/2024 Food and Beverage Undisputed 01/23/2026 1133893653 CMS
Vanda Pharmaceuticals Inc. $125.00 06/25/2024 Food and Beverage Undisputed 01/23/2026 1133954470 CMS
Vanda Pharmaceuticals Inc. $123.34 07/24/2024 Food and Beverage Undisputed 01/23/2026 1133954472 CMS
Vanda Pharmaceuticals Inc. $106.75 09/26/2024 Food and Beverage Undisputed 01/23/2026 1133954474 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.